FRI0182 A Single Dose Study Comparing Pharmacokinetics, Safety, and Immunogenicity of M923 (A Proposed Biosimilar To Adalimumab), US-Sourced Adalimumab, and EU-Sourced Adalimumab in Healthy Subjects

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hillson, J; Mant, T; Ganguly, T; Rosano, M; Huntenburg, C; Alai-Safar, M; Darne, S; Palmer, D; Pavlova, B; Doralt, J; Reeve, R; Goel, N; Weilert, D; Rhyne, P; Caminis, J; Roach, J

Published Date

  • June 2016

Published In

Volume / Issue

  • 75 / Suppl 2

Start / End Page

  • 495.3 - 496

Published By

Electronic International Standard Serial Number (EISSN)

  • 1468-2060

International Standard Serial Number (ISSN)

  • 0003-4967

Digital Object Identifier (DOI)

  • 10.1136/annrheumdis-2016-eular.3706